2Eilber,FC,Rosen,G,Nelson,SD.High grade extremity soft tissue sarcomas. Factor predictive of local recurrence and its effect on morbidity and mortality. Annals of Surgery . 2003
3Vigil CE,Chiappori AA.Phase II study of sunitinib malate (SM) in subjects with metastatic and/or surgically unresectabl enon-GIST soft tissue sarcomas. Symposium of ASCO . 2008
4Macapinlac M,Elrafei T,CunninghamI,et al.Dermattofibrosar-coma protuberans:neoadjuvant therpy with imatinib mesylate anduse of plasma PDGF-βlevels to monitor clinical response. Symposium of ASCO . 2004
5Peabody T D,Gibbs C P Jr,Simon M A. Evaluation and staging of musculoskeletal neoplasms[J]. J Bone Joint Surg Am, 1998, 80 (8) :1204-1218.
6Ozzello L,Stout A P,Murray M R. Cultural characteristics of ma lignant histiocytomas and fibrous xanthomas[J]. Cancer, 1963,16 : 331 -344.
7O'Neill J P, Bilsky M H, Kraus D. Head and neck sarcomas:epidemiology, pathology, and management [J]. Neurosurg Clin N Am,2013,24(1) ,67-78.
8Akpinar A, Ozdemir C O, Ucler N, et al. Storiform pleomorphic type of multifocal malignant fibrous histiocytoma of the lumbar spine[J]. AmJ CaseRep,2014,15..565 568.
9Engellau J, Bendahl P O, Persson A, et al. Improved prognostication in soft tissue sarcoma:independent in[ormation from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays[J]. Hum Pathol, 2005,36 (9) :994-1002.
10Zhao F, A hlawat S,Farahani S J, et al. Can MR imaging be used to predict tumor grade in soft-tissue sarcoma? [J]. Radiology, 2014,272(1) : 192 201.
